The Exon Junction Complex Core Represses Cancer-Specific Mature mRNA Re-splicing: A Potential Key Role in Terminating

Yuta Otani1,2, Ken-Ichi Fujita1, Toshiki Kameyama1,3

  • 1Division of Gene Expression Mechanism, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake 470-1192, Aichi, Japan.

Insights

Cancer cells exhibit aberrant mRNA re-splicing. Researchers identified the exon junction complex (EJC) core as a repressor, preventing this in normal cells and acting as an mRNA quality control factor.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • RNA Splicing

Background:

  • Aberrant mRNA re-splicing generating abnormal transcripts/proteins is observed in cancer cells.
  • A mechanism preventing deleterious re-splicing in normal cells is implied but not fully understood.

Purpose of the Study:

  • To identify repressors controlling mRNA re-splicing.
  • To elucidate the role of specific proteins in preventing aberrant splicing in normal cells.

Main Methods:

  • siRNA-based screening to identify mRNA re-splicing repressors.
  • Knock-down experiments targeting core exon junction complex (EJC) proteins (EIF4A3, MAGOH, RBM8A/Y14).

Main Results:

  • Knock-down of EIF4A3 significantly promoted mRNA re-splicing.
  • Knock-down of any core EJC protein recapitulated cancer-specific mRNA re-splicing in normal cells.

Conclusions:

  • The EJC core (EIF4A3, MAGOH, RBM8A) acts as a repressor of mRNA re-splicing.
  • The EJC core functions as a critical mRNA quality control factor to prevent over-splicing in mature mRNA.